{"nctId":"NCT03539900","briefTitle":"Efficacy and Mechanisms of Naltrexone+Bupropion for Binge Eating Disorder","startDateStruct":{"date":"2018-04-17","type":"ACTUAL"},"conditions":["Binge-Eating Disorder"],"count":89,"armGroups":[{"label":"NB Medication","type":"EXPERIMENTAL","interventionNames":["Drug: Bupropion Hydrochloride, Naltrexone Hydrochoride Drug Combination"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Placebo"]}],"interventions":[{"name":"Bupropion Hydrochloride, Naltrexone Hydrochoride Drug Combination","otherNames":["Contrave"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Binge eating disorder (full criteria as described in the American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 5th edition);\n* BMI in the obesity (BMI \\>30 and \\<50) or non-obesity (BMI \\>21.5 and \\<29.9) range;\n* Available for the duration of the treatment and follow-up (15 months);\n* Read, comprehend, and write English at a sufficient level to complete study-related materials.\n\nExclusion Criteria:\n\n* Currently taking opioid pain medications or drugs; or positive drug screen for opiates\n* Currently taking medications that influence eating/weight;\n* History of seizures;\n* Current substance use disorder or other severe psychiatric disturbance (e.g., suicidality);\n* Past or current anorexia nervosa or bulimia nervosa;\n* Pregnant or breastfeeding;\n* Medical status judged by study physician as contraindication.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Binge Eating Frequency","description":"Binge eating will be assessed by interview (Eating Disorder Examination) and the primary outcome is frequency of binge episodes in the past month, comparing baseline and post-treatment. Change is defined as the change in frequency from baseline to post-treatment.\"","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.4","spread":"10.6"},{"groupId":"OG001","value":"5.4","spread":"9.6"}]}]}]},{"type":"PRIMARY","title":"Percent BMI Change","description":"BMI was calculated using measured height and weight. We report percent BMI change using the following formula: (\\[BMI at posttreatment\\] - \\[BMI at baseline\\])/\\[BMI at baseline\\]. Negative values indicate loss.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.0","spread":"11.3"},{"groupId":"OG001","value":"-0.5","spread":"8.9"}]}]}]},{"type":"SECONDARY","title":"Change in Binge Eating Frequency","description":"Binge eating will be assessed by interview (Eating Disorder Examination) and the primary outcome is frequency of binge episodes in the past month, comparing post-treatment and 6 month post-treatment follow up. Change is defined as the change in frequency from post-treatment to 6 months post-treatment.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.67","spread":"6.29"},{"groupId":"OG001","value":"6.00","spread":"9.54"}]}]}]},{"type":"SECONDARY","title":"Change in Binge Eating Frequency","description":"Binge eating will be assessed by interview (Eating Disorder Examination) and the primary outcome is frequency of binge episodes in the past month, comparing post-treatment and 12 month post-treatment follow up. Change is defined as the change in frequency from post-treatment to 12 months post-treatment.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.36","spread":"14.87"},{"groupId":"OG001","value":"5.33","spread":"6.82"}]}]}]},{"type":"SECONDARY","title":"Body Mass Index","description":"BMI was calculated using measured height and weight. We report percent BMI change using the following formula: (\\[BMI at 6 month followup\\] - \\[BMI at posttreatment\\])/\\[BMI at posttreatment\\]. Negative values indicate loss.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.04","spread":"10.51"},{"groupId":"OG001","value":"0.05","spread":"4.28"}]}]}]},{"type":"SECONDARY","title":"Body Mass Index","description":"BMI was calculated using measured height and weight. We report percent BMI change using the following formula: (\\[BMI at 12 month followup\\] - \\[BMI at posttreatment\\])/\\[BMI at posttreatment\\]. Negative values indicate loss.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.20","spread":"12.18"},{"groupId":"OG001","value":"3.43","spread":"7.86"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":43},"commonTop":["Dry Mouth","Constipation","Dizziness","Headache","Nausea"]}}}